Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Concerns ‘no deal’ Brexit will disrupt veterinary medicine supply
Nearly 55 per cent of those who responded to the survey highlighted potential issues with availability of products.
Majority of NOAH members not prepared for ‘hard Brexit’ - survey

Less than 15 per cent of animal health companies are prepared for a ‘hard Brexit’, according to a member survey by the National Office of Animal Health (NOAH).

The findings come shortly after the government published its first planning notice for a potential ‘no deal’ Brexit, to outline contingency plans if the UK leaves the EU without any withdrawal agreement. In this instance, it is thought the UK will automatically revert to the World Trade Organisation (WTO) rules.

However, NOAH’s survey suggests the vast majority of respondents are not fully prepared for this to occur by March next year. In contrast, nearly 60 per cent of companies are prepared for a transition period to December 2020, but even this will not be enough in some cases.

NOAH said the findings raise serious concerns that there will not be enough time to carry out a smooth Brexit, without interrupting the vital supply of veterinary medicines.

The organisation stressed that the lack of preparedness is not down to a lack of effort on the part of animal health companies, but reflects the magnitude and complexity of the task.

Furthermore, the government has not yet set out the exact arrangements that will operate in the UK in case of a ‘no deal’ Brexit, meaning it is difficult for the industry to be sure that they are prepared.

Although companies have been doing extensive contingency planning, nearly 55 per cent of those who responded to the survey highlighted potential issues with availability of products, affecting up to more than 40 per cent of their products.

This could affect the full spectrum of product types, across all animal species, but there are particular concerns about the supply chain for vaccines.

NOAH chair Gaynor Hillier said: “The production and supply of veterinary medicines is totally dependent on complex international supply chains that must continue to function effectively after Brexit, their unique status being recognised in the recent government White Paper.

“Raw materials will need to arrive at manufacturing sites and veterinary medicines will need to be transported across borders to meet market requirements. Any border delays, additional complex processes or increased costs will risk medicines availability for UK vets, farmers and all our animals.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.